BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9398911)

  • 21. Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer.
    Fischbach LA; Correa P; Ramirez H; Realpe JL; Collazos T; Ruiz B; Bravo LE; Bravo JC; Casabon AL; Schmidt BA
    Aliment Pharmacol Ther; 2001 Jun; 15(6):831-41. PubMed ID: 11380321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection.
    Miehlke S; Bayerdörffer E; Lehn N; Mannes GA; Höchter W; Weingart J; Sommer A; Heldwein W; Müller-Lissner S; Bästlein E
    Eur J Gastroenterol Hepatol; 1995 Oct; 7(10):975-8. PubMed ID: 8590144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric colonization of the ferret with Helicobacter species: natural and experimental infections.
    Fox JG; Otto G; Murphy JC; Taylor NS; Lee A
    Rev Infect Dis; 1991; 13 Suppl 8():S671-80. PubMed ID: 1833810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter mustelae isolation from feces of ferrets: evidence to support fecal-oral transmission of a gastric Helicobacter.
    Fox JG; Paster BJ; Dewhirst FE; Taylor NS; Yan LL; Macuch PJ; Chmura LM
    Infect Immun; 1992 Feb; 60(2):606-11. PubMed ID: 1370432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor.
    Coyle WJ; Sedlack RE; Nemec R; Peterson R; Duntemann T; Murphy M; Lawson JM
    Am J Gastroenterol; 1999 Oct; 94(10):2885-9. PubMed ID: 10520838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Gastrointestinal Physiology Working Group of the Universidad Peruana Cayetano Heredia and The Johns Hopkins University.
    Ramirez-Ramos A; Gilman RH; Leon-Barua R; Recavarren-Arce S; Watanabe J; Salazar G; Checkley W; McDonald J; Valdez Y; Cordero L; Carrazco J
    Clin Infect Dis; 1997 Nov; 25(5):1027-31. PubMed ID: 9402351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three treatment schemes with colloidal bismuth subcitrate (Q-ULCER) in peptic ulcer with Helicobacter pylori.
    Suárez MS; González Cansino J; Velasco Ilizalde C; Sabatier CA; Castillo Hernández J
    Arch Med Res; 1999; 30(1):55-9. PubMed ID: 10071426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori.
    Kadayifci A; Uygun A; Polat Z; Kantarcioğlu M; Kılcıler G; Başer O; Ozcan A; Emer O
    Turk J Gastroenterol; 2012 Feb; 23(1):8-13. PubMed ID: 22505373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication: results of a 2-year follow-up.
    Goh KL; Navaratnam P; Peh SC
    Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1157-60. PubMed ID: 8980932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inefficacy of triple therapy and comparison of two different bismuth-containing quadruple regimens as a firstline treatment option for helicobacter pylori.
    Kekilli M; Onal IK; Ocal S; Dogan Z; Tanoglu A
    Saudi J Gastroenterol; 2016; 22(5):366-369. PubMed ID: 27748322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection.
    Wagner S; Varrentrapp M; Haruma K; Lange P; Müller MJ; Schorn T; Soudah B; Bär W; Gebel M
    Z Gastroenterol; 1991 Nov; 29(11):595-8. PubMed ID: 1771934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study.
    Bayerdörffer E; Miehlke S; Lehn N; Mannes GA; Höchter W; Weingart J; Klann H; Sommer A; Heldwein W; Hatz R; Simon T; Bolle KH; Bästlein E; Meining A; Ruckdeschel G; Stolte M
    Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):343-9. PubMed ID: 8781903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter mustelae-induced gastritis and elevated gastric pH in the ferret (Mustela putorius furo).
    Fox JG; Otto G; Taylor NS; Rosenblad W; Murphy JC
    Infect Immun; 1991 Jun; 59(6):1875-80. PubMed ID: 2037349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Status of Five Different Regimens for Empiric First-Line Helicobacter pylori Eradication in Turkey.
    Gungor G; Baglıcakoglu M; Kayacetin E; Biyik M; Ucar R; Goktepe H; Ataseven H; Demir A
    Digestion; 2015; 92(2):55-9. PubMed ID: 26183105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
    Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
    García Pérez A; Valverde de La Osa J; Giménez Samper M; Alonso García I
    Sangre (Barc); 1999 Oct; 44(5):387-8. PubMed ID: 10618919
    [No Abstract]   [Full Text] [Related]  

  • 39. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
    Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
    Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
    Chong SK; Lou Q; Asnicar MA; Zimmerman SE; Croffie JM; Lee CH; Fitzgerald JF
    Pediatrics; 1995 Aug; 96(2 Pt 1):211-5. PubMed ID: 7630671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.